Cervomed Inc (CRVO)

05:17 AM

Analysts Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $27.50 - Defense World

05:17 AM

Apr 19, 2025

What Will CervoMed Inc (NASDAQ: CRVO) Be Like In 2025 - Stocksregister

Apr 19, 2025

Apr 18, 2025

CervoMed Inc. Announces Executive Appointments and Officer Departure By Investing.com - Investing.com South Africa

Apr 18, 2025

Apr 18, 2025

CervoMed Announces Executive Appointments and Changes - MSN

Apr 18, 2025

Apr 18, 2025

CervoMed Inc. Announces Executive Appointments and Officer Departure - Investing.com Australia

Apr 18, 2025

Apr 15, 2025

CervoMed (CRVO) to Present Key Findings on Dementia Drug at Inte - GuruFocus

Apr 15, 2025

Apr 14, 2025

CervoMed (CRVO) Reports Positive Phase 2b Results for Neflamapim - GuruFocus

Apr 14, 2025

Apr 07, 2025

CervoMed Reports Positive Phase 2b Trial Results - TipRanks

Apr 07, 2025

Apr 04, 2025

Brokerages Set CervoMed Inc. (NASDAQ:CRVO) Price Target at $27.50 - Defense World

Apr 04, 2025

Apr 02, 2025

CervoMed To Present Phase 2b Data On Neflamapimod's Impact On DLB At AD/PD 2025 - Nasdaq

Apr 02, 2025

Apr 02, 2025

CervoMed to present results on Phase 2b RewinD-LB study - TipRanks

Apr 02, 2025

Apr 02, 2025

Investigators to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD™ 2025 - GlobeNewswire

Apr 02, 2025

Apr 02, 2025

CervoMed Inc. to Present Clinical Trial Results Showing Neflamapimod Slows Clinical Progression in Dementia with Lewy Bodies in Oral Presentation at AD/PD 2025 - marketscreener.com

Apr 02, 2025

Apr 02, 2025

Virtu Financial LLC Invests $26,000 in CervoMed Inc. (NASDAQ:CRVO) - Defense World

Apr 02, 2025

Mar 31, 2025

Biotech Stocks Q1 2025 Recap: Winners And Underperformers - Seeking Alpha

Mar 31, 2025

Mar 28, 2025

CervoMed (CRVO) Projected to Post Quarterly Earnings on Friday - Defense World

Mar 28, 2025

Mar 28, 2025

FY2025 EPS Estimates for CervoMed Lowered by Chardan Capital - Defense World

Mar 28, 2025

Mar 27, 2025

CervoMed (NASDAQ:CRVO) Given Buy Rating at D. Boral Capital - Defense World

Mar 27, 2025

Mar 27, 2025

12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga

Mar 27, 2025

Mar 26, 2025

12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga

Mar 26, 2025

Mar 25, 2025

CervoMed Announces Oral Presentation at 19th International - GlobeNewswire

Mar 25, 2025

Mar 25, 2025

CervoMed Inc. to Present Findings on Neflamapimod in Dementia with Lewy Bodies at AP/PD™ Conference 2025 - Nasdaq

Mar 25, 2025

Mar 25, 2025

CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer's and Parkinson's Diseases and Related Neurologic Disorders (AP/PD™) - The Manila Times

Mar 25, 2025

Mar 25, 2025

CervoMed Announces Oral Presentation at 19th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurologic Disorders (AP/PD™) - TradingView

Mar 25, 2025

Mar 25, 2025

New Clinical Data: CervoMed's Breakthrough Dementia Drug Results Revealed at Global Conference - Stock Titan

Mar 25, 2025

Mar 24, 2025

12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga

Mar 24, 2025

Mar 22, 2025

CervoMed: Extension Study Data In Dementia With Lewy Bodies Is Potentially Exciting, With Caveats - Seeking Alpha

Mar 22, 2025

Mar 22, 2025

CervoMed Stock: Extension Study Data In Dementia Is Potentially Exciting, With Caveats - Seeking Alpha

Mar 22, 2025

Mar 21, 2025

12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga

Mar 21, 2025

Mar 21, 2025

Brokers Offer Predictions for CervoMed Q1 Earnings - Defense World

Mar 21, 2025

Mar 20, 2025

Q1 Earnings Forecast for CervoMed Issued By Roth Capital - Defense World

Mar 20, 2025

Mar 19, 2025

Is CervoMed Inc. (CRVO) Among the Best Short Squeeze Stocks to Buy According to Analysts? - Insider Monkey

Mar 19, 2025

Mar 19, 2025

CervoMed reports FY24 EPS ($2.02), consensus ($1.85) - MSN

Mar 19, 2025

Mar 19, 2025

CervoMed Inc (CRVO) Reports Q4 Net Loss of $16.3 Million, Grant Revenue at $9.7 Million - GuruFocus.com

Mar 19, 2025

Mar 19, 2025

Roth Mkm Issues Positive Forecast for CervoMed (NASDAQ:CRVO) Stock Price - Defense World

Mar 19, 2025

Mar 19, 2025

CervoMed (NASDAQ:CRVO) Given New $21.00 Price Target at Canaccord Genuity Group - Defense World

Mar 19, 2025

Mar 19, 2025

Best Biotech Stocks To Watch Now – March 17th - Defense World

Mar 19, 2025

Mar 19, 2025

10 Best Short Squeeze Stocks To Buy According to Analysts - Insider Monkey

Mar 19, 2025

Mar 18, 2025

CervoMed price target raised to $20 from $15 at Roth MKM - TipRanks

Mar 18, 2025

Mar 18, 2025

Following A Monumental March, Can CRVO Keep The Rally Going In April? - RTTNews

Mar 18, 2025

Mar 18, 2025

CervoMed sees cash runway into mid-2026 - MSN

Mar 18, 2025

Mar 18, 2025

CervoMed Full Year 2024 Earnings: Revenues Beat Expectations, EPS Lags - Simply Wall St

Mar 18, 2025

Mar 18, 2025

CervoMed price target raised to $21 from $12 at Canaccord - TipRanks

Mar 18, 2025

Mar 18, 2025

CervoMed Inc. (CRVO): The Best Short-Term Stock to Buy Right Now - Insider Monkey

Mar 18, 2025

Mar 18, 2025

Cervomed Inc. Faces Financial Hurdles Due to Regulatory Restrictions on Public Float - TipRanks

Mar 18, 2025

Mar 17, 2025

Small Cap Stocks To Watch NowMarch 13th - MarketBeat

Mar 17, 2025

Mar 17, 2025

Peering Into CervoMed's Recent Short Interest - Benzinga

Mar 17, 2025